Symetryx Corp 4
4 · NeuBase Therapeutics, Inc. · Filed Sep 11, 2023
Insider Transaction Report
Form 4
Symetryx Corp
10% Owner
Transactions
- Sale
Common Stock, Par Value $0.0001 per Share
2023-09-07$1.80/sh−74,852$134,734→ 605,149 total - Sale
Common Stock, Par Value $0.0001 per Share
2023-09-08$1.53/sh−128,847$197,136→ 476,302 total - Sale
Common Stock, Par Value $0.0001 per Share
2023-09-11$1.44/sh−3,376$4,861→ 472,926 total
Footnotes (1)
- [F1]Of the 472,926 shares listed on Table I in Column 5 as beneficially owned by Symetryx Corporation prior to filing this Form 4: Symetryx Corporation beneficially owns 282,445 shares; Barry Shiff, an individual through his retirement accounts, beneficially owns 109,508 shares; and Aleta Shiff, an individual through her retirement accounts, beneficially owns 80,973 shares. As reported on the Schedule 13D dated August 30, 2023, these three shareholders may be deemed to beneficially own the shares of common stock beneficially owned by each other.